1 |
Munoz, N., X. Bosch, S. de Snajose, R. Herrero, X. Castellsague, K. V. Shah, P. J. F. Sanijders and C. J. L. M. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348, 518-527
DOI
ScienceOn
|
2 |
Lazacano-Ponce, E., R. Herrero and N. Munoz. 2001. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int. J. Cancer 91, 412-420
DOI
ScienceOn
|
3 |
Kinney, W. K, M. M. Manos, L. B. Hurley and J. E. Ransely. 1998. Where's the high-grade cervical neoplesia? the importance of minimally abnormal Papanicolaou diagnoses. Obstet. Gynecol. 91, 973-976
DOI
ScienceOn
|
4 |
National Institutes of Health Consensus Development Conference statement on cervical cancer, 1997. Gynecol. Oncol. 66, 351-361
DOI
ScienceOn
|
5 |
Recommendations for cervical screening 1997. Members of the Working Party on Cervical Screening. 1998. N. Z. Med. J. 111, 94-98
|
6 |
Sherman, M. E., M. H. Schiffman and A. T. Lorincz. 1994. Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am. J. Clin. Pathol. 102, 182-187
DOI
|
7 |
Stoler, M. H. 2000. Advances in Cervical Screening Technology. Mod. Pathol. 3, 275-284
DOI
ScienceOn
|
8 |
Zur Hausen, H. 1988. Papillomavirus in human cancers. Mol. Carcinog. 1, 147-150
DOI
ScienceOn
|
9 |
Wright, T. C., X. W. Sun and J. Koulos. 1995. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet. Gynecol. 85, 202-210
DOI
ScienceOn
|
10 |
Kim, S. R., S. Y. Song, D .S. Kim, J. W. Lee, C. S. Park, D. S. Bae, H. J. Lee, K. T. Kim, O. J. Kwon, E. S. Song, H. J. Joo and G. W. Ahn. 2004. Evaluation of self-collected pad sampling for the detection of HPV in cervicovaginal secretion. The Korean Journal of Pathology 38, 258-264
|
11 |
Rozendaal, L., J. M. Walboomers, J. C. van der Linden, F. J. Voorhorst, P. Kenemans, T. J. Helmerhorst, M. van Ballegooijen and C. J. Meijer. 1996. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int. J. Cancer 68, 766-769
DOI
ScienceOn
|
12 |
Kahang, J. M. and H. J. Lee. 2008. Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study. Korean J. Lab. Med. 28, 70-78.
DOI
ScienceOn
|
13 |
Hong, S. H., D. H. Lee and H. R. Shin. 2004. Prevalence of human papillomavirus infection in women in South Korea. The Korean Journal of Cytopathology 15, 17-27
|
14 |
Hwang, T. S. 1999. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korea women. J. Korean Med. Sci. 14, 593-599
DOI
ScienceOn
|
15 |
Cox, J. T., A. T. Lorincz, M. H. Schiffman, M. E. Sherman, A. Cullen and R J. Kurman. 1995. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 172, 946-954
DOI
ScienceOn
|
16 |
An, H. J., N. H. Cho, S. Y. Lee, I. H. Kim, C. Lee, S. J. Kim, M. S. Mun, S. H. Kim and J. K. Jeong. 2003. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97, 1672-1680
DOI
ScienceOn
|
17 |
Clifford, G. M., J. S. Smith, M. Plummer, N. Munoz and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88, 63-73
DOI
ScienceOn
|
18 |
Bosch, F. X., A. Lorincz, N. Munoz, C. J. L. M. Meijier and K. V. Shako 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55, 244-265
DOI
ScienceOn
|